Macular Degeneration

Macular degeneration usually refers to age-related macular degeneration (AMD), a chronic eye condition that affects the macula, the central part of the retina responsible for sharp, detailed vision used for reading, driving, and recognizing faces. It is commonly divided into dry AMD and wet AMD. Dry AMD tends to progress more slowly and is associated with drusen deposits and thinning or dysfunction of retinal pigment cells, while wet AMD involves abnormal blood vessel growth under or within the retina that can leak fluid or blood and sometimes causes faster vision changes.

Treatment options vary because the biology, pace, and risk profile differ substantially between dry and wet disease. In conventional care, urgent retinal evaluation and anti-VEGF injections are central for wet AMD, while nutritional strategies and monitoring are more relevant for many people with intermediate dry AMD. Complementary and Eastern approaches are often explored for symptom support, quality of life, stress reduction, circulation-oriented traditions, and adjunctive nutritional support, but their evidence base is generally less definitive than standard ophthalmology treatments. Because central vision loss can overlap with other serious retinal problems, individualized evaluation by an eye clinician remains important.